Parkinson’s Generic Transdermal Drug Delivery System
Jun 8, 2020
Vancouver, Canada (June 8, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its wholly...
Exclusive Agreement with Oettinger Brewery for Cannabis-Infused Beverages signed
May 12, 2020
Vancouver, Canada (May 12, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that it has...
Infectious Disease Oral Dissolvable Biosensor Development
Apr 22, 2020
Vancouver, Canada (April 22, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that further to...
COVID-19 Screening Test, Oral Thin Film Biosensor Products and Identification Platform
Apr 20, 2020
Vancouver, Canada (April 20, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that it has...
Exclusive Advisory Agreement for COVID-19 and Host Cell Interactions Signed
Mar 25, 2020
Vancouver, Canada (March 25, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY) (FSE:4XT) (OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that an exclusive infectious disease...
COVID-19 Test and Development Programs Update
Mar 20, 2020
Vancouver, Canada (March 20, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY) (FSE:4XT) (OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce updates to its infectious disease...
Update on XPhyto’s Epilepsy Treatment Program
Mar 18, 2020
Vancouver, Canada (March 18, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce significant progress with respect to development...
XPhyto Initiates Infectious Disease Programs
Mar 3, 2020
Vancouver, Canada (March 03, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that its wholly owned German subsidiary,...
Exclusive Strategic Partnership Commenced with Elite Bavarian Brewing & Beverage Institute Weihenstephan (TUM)
Feb 18, 2020
Vancouver, Canada (February 18, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that its wholly owned German subsidiary,...
Three Year Strategic Supply, Import and Distribution Agreement with PharmaCielo Ltd. signed
Jan 27, 2020
Vancouver, Canada (January 27, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that the Company has signed a...
XPhyto Therapeutics developing Epilepsy Treatment with Oral Thin Film Delivery System
Dec 6, 2019
Vancouver, Canada (December 6, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that the development of Epilepsy treatment...
XPhyto Therapeutics pharmaceutical-grade Cannabis Extraction Lab
Nov 26, 2019
Vancouver, Canada (November 25, 2019) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that the Company’s pharmaceutical grade extraction...
